Anosmia, mild cognitive impairment, and biomarkers of brain aging in older adults
- PMID: 36341691
- DOI: 10.1002/alz.12777
Anosmia, mild cognitive impairment, and biomarkers of brain aging in older adults
Abstract
Olfactory impairment is a potential marker for prodromal dementia, but the underlying mechanisms are poorly understood. This population-based study included 4214 dementia-free participants (age ≥65 years). Olfaction was assessed using the 16-item Sniffin' Sticks identification test. In the subsamples, we measured plasma amyloid beta (Aβ)40, Aβ42, total tau, and neurofilament light chain (NfL; n = 1054); and quantified hippocampal, entorhinal cortex, and white matter hyperintensity (WMH) volumes, and Alzheimer's disease (AD)-signature cortical thickness (n = 917). Data were analyzed with logistic and linear regression models. In the total sample, mild cognitive impairment (MCI) was diagnosed in 1102 persons (26.2%; amnestic MCI, n = 931; non-amnestic MCI, n = 171). Olfactory impairment was significantly associated with increased likelihoods of MCI, amnestic MCI, and non-amnestic MCI. In the subsamples, anosmia was significantly associated with higher plasma total tau and NfL concentrations, smaller hippocampal and entorhinal cortex volumes, and greater WMH volume, and marginally with lower AD-signature cortical thickness. These results suggest that cerebral neurodegenerative and microvascular lesions are common neuropathologies linking anosmia with MCI in older adults.
Keywords: brain aging; mild cognitive impairment; neurodegeneration; olfaction; population-based study; white matter hyperintensity.
© 2022 the Alzheimer's Association.
Similar articles
-
White matter hyperintensities and amyloid are independently associated with entorhinal cortex volume among individuals with mild cognitive impairment.Alzheimers Dement. 2013 Oct;9(5 Suppl):S124-31. doi: 10.1016/j.jalz.2012.11.009. Epub 2013 Jan 30. Alzheimers Dement. 2013. PMID: 23375566 Free PMC article.
-
Multimorbidity, cognitive phenotypes, and Alzheimer's disease plasma biomarkers in older adults: A population-based study.Alzheimers Dement. 2024 Mar;20(3):1550-1561. doi: 10.1002/alz.13519. Epub 2023 Dec 2. Alzheimers Dement. 2024. PMID: 38041805 Free PMC article.
-
Olfaction, Cognitive Impairment, and PET Biomarkers in Community-Dwelling Older Adults.J Alzheimers Dis. 2022;86(3):1275-1285. doi: 10.3233/JAD-210636. J Alzheimers Dis. 2022. PMID: 35180111 Free PMC article.
-
Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.Cochrane Database Syst Rev. 2020 Mar 2;3(3):CD009628. doi: 10.1002/14651858.CD009628.pub2. Cochrane Database Syst Rev. 2020. PMID: 32119112 Free PMC article.
-
Core candidate neurochemical and imaging biomarkers of Alzheimer's disease.Alzheimers Dement. 2008 Jan;4(1):38-48. doi: 10.1016/j.jalz.2007.08.006. Epub 2007 Dec 21. Alzheimers Dement. 2008. PMID: 18631949 Review.
Cited by
-
Enlarged choroid plexus is linked with poorer physical function in rural older adults: a population-based study.Fluids Barriers CNS. 2025 Apr 3;22(1):33. doi: 10.1186/s12987-025-00642-z. Fluids Barriers CNS. 2025. PMID: 40176085 Free PMC article.
-
Brodmann Areas, V1 Atlas and Cognitive Impairment: Assessing Cortical Thickness for Cognitive Impairment Diagnostics.Medicina (Kaunas). 2024 Mar 31;60(4):587. doi: 10.3390/medicina60040587. Medicina (Kaunas). 2024. PMID: 38674233 Free PMC article.
-
Olfactory dysfunction as potential biomarker in neurodegenerative diseases: a narrative review.Front Neurosci. 2025 Jan 7;18:1505029. doi: 10.3389/fnins.2024.1505029. eCollection 2024. Front Neurosci. 2025. PMID: 39840019 Free PMC article. Review.
-
Trajectories of olfactory identification preceding incident mild cognitive impairment and dementia: a longitudinal study.EBioMedicine. 2023 Dec;98:104862. doi: 10.1016/j.ebiom.2023.104862. Epub 2023 Oct 28. EBioMedicine. 2023. PMID: 38251465 Free PMC article.
-
Neurons, Nose, and Neurodegenerative Diseases: Olfactory Function and Cognitive Impairment.Int J Mol Sci. 2023 Jan 20;24(3):2117. doi: 10.3390/ijms24032117. Int J Mol Sci. 2023. PMID: 36768440 Free PMC article. Review.
References
REFERENCES
-
- Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256(3):183-194.
-
- Knopman DS, Amieva H, Petersen RC, et al. Alzheimer disease. Nat Rev Dis Primers. 2021;7(1):33.
-
- Ubeda-Banon I, Saiz-Sanchez D, Flores-Cuadrado A, et al. The human olfactory system in two proteinopathies: Alzheimer's and Parkinson's diseases. Transl Neurodegener. 2020;9(1):22.
-
- Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. 2006;112(4):389-404.
-
- Lowe VJ, Bruinsma TJ, Wiste HJ, et al. Cross-sectional associations of tau-PET signal with cognition in cognitively unimpaired adults. Neurology. 2019;93(1):e29-e39.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical